For the Quarter Ending June 2026
Sulfamethoxazole Prices in North America
- In United States, the Sulfamethoxazole Price Index rose in Q2 2026, driven by firming feedstock and robust demand.
- Sulfamethoxazole production costs increased in Q2 2026, influenced by a 5.5% year-over-year rise in producer prices in June 2026.
- Demand for Sulfamethoxazole saw robust buying in Q2 2026, for UTI treatment and PCP prophylaxis procurement.
- The Sulfamethoxazole Price Index was supported by a 3.5% year-over-year consumer price increase in June 2026.
- Sulfonamide synthesis feedstock costs firmed in Q2 2026, elevating the API production floor.
- A strong labor market, with unemployment at 4.2% in June 2026, supported healthcare access and pharmaceutical demand.
- Robust retail sales growth of 6.9% year-over-year in May 2026 supported consumer spending and healthcare utilization.
- U.S. industrial production grew sluggishly by 0.7% year-over-year in June 2026, indicating a subdued economic backdrop.
- Global oil inventories drew down sharply in Q2 2026, while Brent crude oil spot prices peaked during the quarter.
Why did the price of Sulfamethoxazole change in June 2026 in North America?
- Producer prices rose 5.5% in June 2026, directly increasing Sulfamethoxazole manufacturing costs.
- Sulfonamide synthesis feedstock costs firmed in Q2 2026, elevating API production floor.
- Robust procurement for UTI treatment lifted Sulfamethoxazole demand in Q2 2026.
Sulfamethoxazole Prices in Europe
- In Germany, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q2 2026, driven by mounting production costs and feedstock increases.
- Sulfamethoxazole production costs mounted in Q2 2026, influenced by a 2.2% rise in producer prices in May 2026.
- The Sulfamethoxazole Price Index is forecast to face downward pressure in the coming quarter due to anticipated production cutbacks.
- Sulfamethoxazole demand outlook was mixed in Q2 2026, with a contracting Manufacturing Index in June 2026.
- Germany's industrial production remained unchanged at 0.0% in May 2026, indicating stable demand for chemical intermediates.
- Benzene feedstock costs spiked in May 2026, while aniline prices dropped sharply in Q2 2026, impacting input costs.
- Consumer price inflation slowed to +2.3% in June 2026, with retail sales increasing by 1.8% in May 2026.
- The unemployment rate remained stable at 3.8% in May 2026, supporting consumer income and healthcare spending.
Why did the price of Sulfamethoxazole change in June 2026 in Europe?
- Producer prices rose by 2.2% in May 2026, and benzene feedstock costs spiked in May 2026.
- A contracting Manufacturing Index and negative consumer confidence in June 2026 dampened demand.
- Overall energy and raw material costs mounted in Q2 2026, despite aniline prices dropping sharply.
Sulfamethoxazole Prices in APAC
- In China, the Sulfamethoxazole Price Index rose in Q2 2026, driven by increased production costs and robust demand.
- Production costs increased in Q2 2026, influenced by a 4.1% year-on-year PPI rise in June 2026.
- Demand for Sulfamethoxazole was strong in Q2 2026, supported by expanding domestic API demand.
- China's Manufacturing Index expanded in June 2026, indicating growth in the broader manufacturing sector.
- Energy prices, including Brent crude and LNG, rose in Q2 2026 due to Middle East conflict.
- The average price of Sulfamethoxazole in CFR Bangladesh is USD 16000/MT.
- Industrial production grew 5.3% year-on-year in June 2026, signaling a robust manufacturing base.
- Stable consumer prices (1.0% CPI) and retail sales (1.0%) in June 2026 supported purchasing power.
Why did the price of Sulfamethoxazole change in June 2026 in APAC?
- Production costs rose in Q2 2026, influenced by a 4.1% year-on-year PPI increase in June 2026.
- Energy price volatility and tightened feedstock supplies, like butane and naphtha, elevated costs in Q2 2026.
- Robust API demand and 5.3% industrial production growth in June 2026 supported Sulfamethoxazole price increases.
For the Quarter Ending March 2026
Sulfamethoxazole Prices in North America
- In United States, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- The Sulfamethoxazole Production Cost Trend increased during January-March 2026 as producer prices rose 4.0% year-over-year.
- Toluene and aniline feedstock costs surged in March 2026, elevating the overall Sulfamethoxazole Price Index.
- The Sulfamethoxazole Demand Outlook strengthened in Q1 2026, supported by a 4.0% year-over-year retail sales increase.
- Consumer confidence reached 91.8 in March 2026, sustaining out-of-pocket healthcare spending and broad-spectrum antibiotic demand.
- Industrial production grew 0.7% year-over-year in March 2026, while the Manufacturing Index expanded in February 2026.
- A stable 4.3% unemployment rate in March 2026 maintained healthcare coverage, supporting consistent prescription fulfillment.
- Consumer prices increased 3.3% year-over-year in March 2026, raising transportation and logistics costs for pharmaceuticals.
- The Sulfamethoxazole Price Forecast remained elevated in Q1 2026 due to severe import rerouting and delays.
Why did the price of Sulfamethoxazole change in March 2026 in North America?
- Toluene and aniline raw material pricing faced upward pressure in Q1 2026 amid energy volatility.
- Global active pharmaceutical ingredient supply tightened in Q1 2026 due to geopolitical transit route disruptions.
- Downstream demand for broad-spectrum antibiotics strengthened in Q1 2026 due to seasonal infection treatment protocols.
Sulfamethoxazole Prices in APAC
- In China, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q1 2026, driven by escalating upstream benzene feedstock costs.
- The Sulfamethoxazole Production Cost Trend increased in March 2026 as the Producer Price Index rose 0.5% year-over-year.
- The Sulfamethoxazole Demand Outlook remained stable in March 2026, supported by a 1.0% year-over-year Consumer Price Index increase.
- Industrial production grew 5.7% year-over-year in March 2026, ensuring robust baseline supply for Sulfamethoxazole pharmaceutical formulation end-uses.
- An urban unemployment rate of 5.4% in March 2026 pressured veterinary Sulfamethoxazole demand as farmers reduced prophylactic usage.
- Retail sales grew 1.7% year-over-year in March 2026, reflecting softer consumer spending on retail veterinary Sulfamethoxazole products.
- Domestic chemical inventories tightened in March 2026 as Chinese refiners prioritized fuel production over Sulfamethoxazole intermediate chemical output.
- The Sulfamethoxazole Price Forecast reflected upward momentum in Q1 2026 due to inflated global pharmaceutical excipient input costs.
Why did the price of Sulfamethoxazole change in March 2026 in APAC?
- Upstream benzene feedstock costs escalated sharply following severe Middle East geopolitical disruptions in March 2026.
- Domestic chemical inventories tightened as Chinese refiners prioritized fuel production over chemical output in March 2026.
- The Producer Price Index rose 0.5% year-over-year in March 2026, pushing factory-gate manufacturing costs higher.
Sulfamethoxazole Prices in Europe
- In Germany, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock and energy costs.
- The Sulfamethoxazole Production Cost Trend increased in March 2026 as the 2.7% CPI YoY elevated operational expenses.
- Despite a -0.2% PPI YoY in March 2026, upstream naphtha and benzene feedstock costs jumped significantly.
- The Manufacturing Index expanded in March 2026, tightening fine chemical supplies and supporting the Sulfamethoxazole Demand Outlook.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, sustaining human healthcare medication demand.
- Consumer confidence dropped to -24.7 in March 2026, negatively impacting discretionary spending on veterinary pharmaceutical end-uses.
- Chemical tanker freight rates soared in March 2026 due to Middle East conflicts, disrupting European supply chains.
- The Sulfamethoxazole Price Forecast indicated continued upward pressure throughout Q1 2026 due to tightened regional production capacity.
Why did the price of Sulfamethoxazole change in March 2026 in Europe?
- Benzene and naphtha feedstock costs jumped sharply in Europe during March 2026, elevating production expenses.
- European natural gas prices surged significantly in March 2026, increasing energy costs for chemical synthesis.
- Middle East conflicts disrupted supply chains, causing chemical freight rates to soar in March 2026.
For the Quarter Ending December 2025
Sulfamethoxazole Prices in APAC
- In China, the Sulfamethoxazole Price Index declined quarter-over-quarter in Q4 2025, due to weak demand and market oversupply.
- Sulfamethoxazole production costs decreased in Q4 2025, as producer prices declined by 1.9% year-over-year in December 2025.
- Sulfamethoxazole demand outlook was subdued, with retail sales growing only 0.9% year-over-year in December 2025.
- The Manufacturing Index expanded in December 2025, indicating growth in the broader manufacturing sector.
- Industrial production increased by 5.2% year-over-year in December 2025, supporting chemical input demand.
- Benzene feedstock costs declined in October 2025, contributing to lower Sulfamethoxazole manufacturing expenses.
- East China port acetone inventories significantly climbed in October 2025, reflecting persistent market oversupply.
- Weak consumer inflationary pressure, with CPI at 0.8% year-over-year in December 2025, impacted demand.
- A moderate unemployment rate of 5.1% in December 2025 influenced consumer disposable income.
Why did the price of Sulfamethoxazole change in December 2025 in APAC?
- Producer prices declined by 1.9% in December 2025, reducing Sulfamethoxazole manufacturing costs.
- Weak demand for acetone, a key precursor, persisted in October 2025, impacting Sulfamethoxazole.
- East China port acetone inventories significantly climbed in October 2025, contributing to oversupply.
Sulfamethoxazole Prices in North America
- In United States, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q4 2025, driven by intensifying production costs and moderate demand.
- Sulfamethoxazole production costs faced upward pressure in Q4 2025, as general chemical manufacturing expenses intensified.
- The Producer Price Index (PPI) increased 3.0% year-over-year in November 2025, reflecting rising input costs.
- Consumer Price Index (CPI) rose 2.7% year-over-year in December 2025, indicating general inflation affecting raw materials.
- Demand for Sulfamethoxazole was supported by growing pharmaceutical production and sales globally in 2025.
- Industrial production increased 2.0% year-over-year in December 2025, indirectly bolstering healthcare spending.
- US Henry Hub natural gas spot prices gradually rose in late 2025, impacting Sulfamethoxazole energy costs.
- US chemical imports and exports were projected to reach their lowest levels since 2020/2021 in 2025.
- Industry-wide destocking cycles were waning in 2025, influencing inventory levels for related chemicals.
Why did the price of Sulfamethoxazole change in December 2025 in North America?
- Sulfamethoxazole production costs rose due to a 3.0% PPI increase in November 2025 and higher energy costs.
- Demand was supported by a 3.3% rise in retail sales in November 2025 and growing pharmaceutical sector activity.
- Reduced US chemical trade volumes in 2025, influenced by geopolitical tensions, impacted Sulfamethoxazole supply.
Sulfamethoxazole Prices in Europe
- In Germany, the Sulfamethoxazole Price Index remained stable in Q4 2025, amidst contracting manufacturing activity in December 2025.
- Sulfamethoxazole production costs declined in December 2025, driven by a 2.5% year-over-year decrease in producer prices.
- Demand for Sulfamethoxazole was supported by positive indicators within Germany's pharmaceutical sector in December 2025.
- The Sulfamethoxazole Price Forecast suggests stability, as moderate 1.8% inflation in December 2025 balanced lower input costs.
- Industrial production in Germany inched up by 0.8% year-over-year in October 2025, indirectly supporting chemical demand.
- Weak export volumes for German chemical and pharmaceutical industries hampered trade flows in December 2025.
- High industrial natural gas costs throughout 2025 challenged Sulfamethoxazole production competitiveness.
- Consumer confidence declined significantly to -17.5 in December 2025, indirectly influencing healthcare spending.
- Germany's Manufacturing Index showed a contracting trend in December 2025, signaling a weaker economic outlook.
Why did the price of Sulfamethoxazole change in December 2025 in Europe?
- Producer prices declined by 2.5% year-over-year in December 2025, reducing Sulfamethoxazole manufacturing costs.
- Weak export volumes for German chemical and pharmaceutical industries hampered trade in December 2025.
- High industrial natural gas costs persisted throughout 2025, impacting overall production expenses.
For the Quarter Ending September 2025
Sulfamethoxazole Prices in North America
- In United States, Sulfamethoxazole Price Index fell in Q3 2025, due to oversupply and deteriorating chemical demand.
- Production costs for Sulfamethoxazole rose in Q3 2025, with PPI up 2.6% in August and CPI up 3.0% in September.
- Medical sector demand strengthened during H2 2025, providing support for Sulfamethoxazole consumption.
- Industrial production grew only 0.1% in September 2025, reflecting broader market weakness and falling new orders.
- Chemical industry inventories tightened in Q3 2025, driven by accelerating destocking efforts.
- US chemical import and export volumes contracted in 2025, influenced by tariff friction during Q3 2025.
- Natural gas prices inched up in September 2025, while crude oil prices weakened in July-August 2025.
- Strong retail sales, up 5.42% in September 2025, and low 4.3% unemployment supported human pharmaceutical demand.
- Consumer confidence declined to 94.2 in September 2025, signaling potential headwinds for overall economic activity.
Why did the price of Sulfamethoxazole change in September 2025 in North America?
- Oversupply in the chemical industry during Q3 2025 exerted downward pressure.
- Major customer market demand for chemicals deteriorated in Q3 2025, reducing new orders.
- Rising input/raw materials and energy costs in Q3 2025 increased production expenses.
Sulfamethoxazole Prices in APAC
- In China, the Sulfamethoxazole Price Index fell quarter-over-quarter, driven by weak industrial demand and falling factory-gate prices.
- Sulfamethoxazole price forecast indicates continued pressure from persistent overcapacity and pessimistic consumer confidence in September 2025.
- Sulfamethoxazole production costs saw mixed trends; benzene feedstock stabilized, but manufacturing input prices jumped in July 2025.
- Demand outlook for Sulfamethoxazole remains sustained by an aging population and chronic diseases in 2025.
- The Sulfamethoxazole Price Index faced downward pressure from -0.3% CPI and -2.3% PPI year-over-year in September 2025.
- China's Manufacturing Index contracted July-August 2025, though new orders and production expanded in September 2025.
- Retail sales grew 3.0% year-over-year in September 2025, supporting consumer spending on healthcare.
- Raw materials inventory for manufacturing remained below threshold in August and September 2025, amidst global overcapacity.
Why did the price of Sulfamethoxazole change in September 2025 in APAC?
- Weak industrial demand, reflected by a contracting Manufacturing Index in September 2025, pressured pricing.
- Falling factory-gate prices, with PPI down -2.3% year-over-year in September 2025, contributed to lower selling prices.
- Persistent global overcapacity in chemical building blocks throughout Q3 2025 created a competitive market.
Sulfamethoxazole Prices in Europe
- In Germany, the Sulfamethoxazole Price Index fell quarter-over-quarter in Q3 2025, influenced by contracting industrial production.
- Sulfamethoxazole production costs faced pressure from high energy costs and a 2.4% CPI increase in September 2025.
- Benzene feedstock costs were bearish in August 2025; the Producer Price Index decreased by 1.7% in September 2025.
- Sulfamethoxazole demand outlook was mixed; pharmaceutical sector demand strengthened in Q3 2025.
- Overall industrial demand remained weak, with German industrial production declining by 1.0% in September 2025.
- High European benzene stock levels and elevated overall chemical inventories persisted in Q3 2025.
- German chemical export orders trended weak in Q3 2025, impacted by US tariffs on pharmaceutical exports.
- Consumer confidence was negative at -23.6 index in September 2025, despite 0.8% retail sales and 3.9% unemployment.
Why did the price of Sulfamethoxazole change in September 2025 in Europe?
- Contracting manufacturing activity and 1.0% industrial production decline in September 2025 reduced overall demand.
- Bearish benzene feedstock costs in August 2025 and 1.7% PPI decrease in September 2025 eased input costs.
- Weak German export orders and increased US imports intensified competition, pressuring prices in Q3 2025.
